HIF1A and COVID-19: This analysis of the change in HIF1A expression over time confirms our hypothesis that the degree of the upregulation of HIF1A in monocytes in early convalescence (2 weeks after disease resolution) is linked to the severity of previous COVID-19 disease symptoms.